Media Feature: Article on Obesity Care in India

Dr. Jothydev Kesavadev was featured in “The Telegraph” in an article examining the evolving obesity treatment landscape in India and the growing demand for GLP-1-based therapies such as semaglutide. The feature highlighted the increasing recognition of obesity as a chronic disease requiring evidence-based medical intervention and discussed the importance of improving access to effective therapies while maintaining a focus on quality, affordability, and long-term patient outcomes.

Technology Transforming Lives in Type 1 Diabetes

A recent patient story shared by the JDC Technology Team highlighted the positive impact of advanced diabetes technology on the life of a young individual living with Type 1 diabetes. Under the care of Jothydev’s Diabetes Research Centre (JDC), the patient has been on insulin pump therapy since 2019 and transitioned to the MiniMed™ 780G Automated Insulin Delivery (AID) system in 2022.

The experience demonstrates how modern diabetes technologies can support improved glycemic management, greater independence, and enhanced quality of life for individuals with Type 1 diabetes. The journey also underscores the vital role of patient education, continuous support, and family involvement in achieving long-term diabetes care goals. Through such real-world success stories, JDC continues to promote awareness of technology-enabled diabetes management and its potential to transform patient outcomes.

22nd P. Kesavadev Awards 2026

The 22nd P. Kesavadev Awards 2026 celebrated excellence in literature and healthcare, commemorating the enduring legacy of the renowned Malayalam writer and social reformer, P. Kesavadev. The event was inaugurated by Hon. Chief Minister Shri V. D. Satheesan, in the presence of Smt. Bindhu Krishna, Hon. Minister for Women & Child Development, Government of Kerala.

The P. Kesavadev Sahithya Puraskaram was conferred on Mr. Subhash Chandran in recognition of his outstanding contributions to Malayalam literature through acclaimed works such as Manushyanu Oru Aamukham and Samudra Shila. The P. Kesavadev Diabscreen Puraskaram was presented to Dr. Thankam Subramanian for her lifelong dedication to advancing diabetes care, patient education, and community health.

The ceremony brought together eminent personalities from the literary, medical, and public spheres, celebrating individuals whose contributions have left a lasting impact on society.

Link 1 | Link 2 | Link 3 | Link 4 | Link 5 | Link 6 | Link 7

Dr. D. Veeraswamy Seshiah Oration at Hello Diabetes Academia

Dr. Jothydev Kesavadev was conferred the prestigious Dr. D. Veeraswamy Seshiah Oration Award at Hello Diabetes Academia, Nagpur. The award was presented by Dr. P. C. Manoria, Dr. Sunil Gupta, Dr. Kavita Gupta, Dr. Shashank R. Joshi, Dr. Shankar Khobragade, and Dr. Rakesh Parikh.

As part of the oration, Dr. Jothydev delivered a lecture on "Use of Technology in Diabetes in Pregnancy," highlighting the transformative role of continuous glucose monitoring (CGM), automated insulin delivery systems, telemedicine, and multidisciplinary care in improving maternal and fetal outcomes. Named in honour of Prof. Dr. V. Seshiah, regarded as the Father of Gestational Diabetes in India, the award recognizes excellence in advancing diabetes care through innovation, research, and clinical practice.

Featured Interview in Malayala Manorama

Dr. Jothydev Kesavadev was featured in an interview published in Malayala Manorama, where he shared expert insights on the growing burden of obesity and its impact on metabolic health. The interview highlighted the importance of early intervention, lifestyle modification, evidence-based treatment strategies, and the evolving role of modern obesity therapies in improving long-term health outcomes.

Article in The New Indian Express

Dr. Jothydev Kesavadev authored an expert article in The New Indian Express on the importance of diabetes screening and management in women planning pregnancy. The article highlighted the need for early identification of diabetes and prediabetes, emphasizing timely evaluation, optimal glycaemic control, and preconception care to ensure healthier maternal and fetal outcomes.